Skip to main content
Top
Published in: Journal of Medical Systems 1/2016

01-01-2016 | Patient Facing Systems

What is Your Risk of Contracting Alzheimer’s Disease? A Telematics Tool Helps you to Predict it

Authors: Rodrigo Méndez-Sanz, Isabel de la Torre-Díez, Miguel López-Coronado

Published in: Journal of Medical Systems | Issue 1/2016

Login to get access

Abstract

Alzheimer’s disease (AD) is the most common dementia in developed countries. Between the identified risk factors, one of the most important is the age. Its prevalence reaches 24 % in men and 33 % in women over 85 years. Increase in life expectancy, making it a serious public health problem. Prevention of Alzheimer’s disease represents a major challenge to health. Given that Alzheimer’s disease is largely dependent on the genetics of each person and uninterrupted progress of the age, which is try to make people aware that there are other factors that can alter your chance of developing the Alzheimer disease and although currently not reduce, help is not increased in the near or distant future.
The aim of this paper is to develop and evaluate a Web-Mobile application (Alzhe Alert) used to calculate the risk of Alzheimer’s from a short questionnaire using a computer or mobile device, so that any user, without requiring computer skills, can access the website to estimate their risk of developing the disease in the coming years depending on their habits and daily basis activities. The users who have realized the questionnaire can to observe in a graph the result, and they will know which is at risk for Alzheimer’s at present and over the next 50 years if they continue with the same habits and lifestyle. The objective is that the users can be aware of the risk they have different habits of life about their health. Currently, 243 users (84 women and 159 men) of white race have completed the questionnaire. 76 % of the users have got a risk below the average.
Literature
1.
go back to reference Thies, W., Alzheimer’s disease neuroimaging initiative: A decade of progress in Alzheimer’s disease. Alzheimers Dement. 11(7):727–729, 2015.PubMedCrossRef Thies, W., Alzheimer’s disease neuroimaging initiative: A decade of progress in Alzheimer’s disease. Alzheimers Dement. 11(7):727–729, 2015.PubMedCrossRef
2.
go back to reference De Pedro-Cuesta, J., Virués-Ortega, J., Vega, S., et al., Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990–2008. BMC Neurol. 9:55, 2009.PubMedPubMedCentralCrossRef De Pedro-Cuesta, J., Virués-Ortega, J., Vega, S., et al., Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990–2008. BMC Neurol. 9:55, 2009.PubMedPubMedCentralCrossRef
3.
go back to reference Castellani, R. J., and Perry, G., Pathogenesis and disease-modifying therapy in Alzheimer’s disease: The flat line of progress. Arch. Med. Res. 43(8):694–698, 2012.PubMedCrossRef Castellani, R. J., and Perry, G., Pathogenesis and disease-modifying therapy in Alzheimer’s disease: The flat line of progress. Arch. Med. Res. 43(8):694–698, 2012.PubMedCrossRef
5.
go back to reference da Silva Lopes, H. F., Abe, J. M., and Anghinah, R., Application of paraconsistent artificial neural networks as a method of aid in the diagnosis of Alzheimer disease. J. Med. Syst. 34(6):1073–1081, 2010.PubMedCrossRef da Silva Lopes, H. F., Abe, J. M., and Anghinah, R., Application of paraconsistent artificial neural networks as a method of aid in the diagnosis of Alzheimer disease. J. Med. Syst. 34(6):1073–1081, 2010.PubMedCrossRef
6.
go back to reference Daliri, M. R., Automated diagnosis of Alzheimer disease using the scale-invariant feature transforms in magnetic resonance images. J. Med. Syst. 36(2):995–1000, 2012.PubMedCrossRef Daliri, M. R., Automated diagnosis of Alzheimer disease using the scale-invariant feature transforms in magnetic resonance images. J. Med. Syst. 36(2):995–1000, 2012.PubMedCrossRef
9.
go back to reference O’Brien J., Ames D., Burns A., Dementia Second Edition: London, 2000. O’Brien J., Ames D., Burns A., Dementia Second Edition: London, 2000.
10.
11.
go back to reference Selkoe, D. J., Alzheimer’s disease: Genes, proteins, and threrapy. Physiol. Rev. 81:741–766, 2001.PubMed Selkoe, D. J., Alzheimer’s disease: Genes, proteins, and threrapy. Physiol. Rev. 81:741–766, 2001.PubMed
12.
go back to reference Levy-Lahad, E., and Dird, T. D., Genetic factors in Alzheimer’s disease: A review of recent advances. Ann. Neurol. 40(6):829–840, 2004.CrossRef Levy-Lahad, E., and Dird, T. D., Genetic factors in Alzheimer’s disease: A review of recent advances. Ann. Neurol. 40(6):829–840, 2004.CrossRef
13.
go back to reference Li, Y. J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., et al., Age at onset in two common degenerative diseases is genetically controlled. Am. J. Hum. Genet. 70(4):985–993, 2002.PubMedPubMedCentralCrossRef Li, Y. J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., et al., Age at onset in two common degenerative diseases is genetically controlled. Am. J. Hum. Genet. 70(4):985–993, 2002.PubMedPubMedCentralCrossRef
14.
go back to reference Viña, J., and Lloret, A., Why women have more Alzheimer’s disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide. J. Alzheimers Dis. 20(Suppl 2):S527–533, 2010.PubMed Viña, J., and Lloret, A., Why women have more Alzheimer’s disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide. J. Alzheimers Dis. 20(Suppl 2):S527–533, 2010.PubMed
16.
go back to reference Bortolon, C., Louche, A., Gély-Nargeot, M. C., and Raffard, S., Do patients suffering from Alzheimer’s disease present an own-age bias in face recognition? Exp. Gerontol. 70:46–53, 2015.PubMedCrossRef Bortolon, C., Louche, A., Gély-Nargeot, M. C., and Raffard, S., Do patients suffering from Alzheimer’s disease present an own-age bias in face recognition? Exp. Gerontol. 70:46–53, 2015.PubMedCrossRef
17.
go back to reference Raggi, A., Tasca, D., Panerai, S., Neri, W., and Ferri, R., The burden of distress and related coping processes in family caregivers of patients with Alzheimer’s disease living in the community. J. Neurol. Sci. 2015. doi:10.1016/j.jns.2015.08.024. Raggi, A., Tasca, D., Panerai, S., Neri, W., and Ferri, R., The burden of distress and related coping processes in family caregivers of patients with Alzheimer’s disease living in the community. J. Neurol. Sci. 2015. doi:10.​1016/​j.​jns.​2015.​08.​024.
18.
go back to reference Newell, K. L., Silver, M. H., Perls, T. T. and Hedley-Whyte, E. T., What centenarians teach us about neuropathology. In: JM Martinez Lage and V Hachinski (Eds.), Envejecimiento cerebral y enfermedad. Editorial Triacastela: 31–46. Madrid, Spain, 2001. Newell, K. L., Silver, M. H., Perls, T. T. and Hedley-Whyte, E. T., What centenarians teach us about neuropathology. In: JM Martinez Lage and V Hachinski (Eds.), Envejecimiento cerebral y enfermedad. Editorial Triacastela: 31–46. Madrid, Spain, 2001.
19.
go back to reference Launer, L., and Hofman, A., Frequency and impact of neurologic diseases in the elderly of Europe: A collaborative study of population-based cohorts. Neurology 54(11 Suppl 5):S1–8, 2000.PubMed Launer, L., and Hofman, A., Frequency and impact of neurologic diseases in the elderly of Europe: A collaborative study of population-based cohorts. Neurology 54(11 Suppl 5):S1–8, 2000.PubMed
20.
go back to reference Whalley, L. J., Starr, J. M., Athawes, R., Hunter, D., Pattle, A., and Deary, I. J., Childhood mental ability and dementia. Neurology 55(10):1455–1459, 2000.PubMedCrossRef Whalley, L. J., Starr, J. M., Athawes, R., Hunter, D., Pattle, A., and Deary, I. J., Childhood mental ability and dementia. Neurology 55(10):1455–1459, 2000.PubMedCrossRef
21.
go back to reference Larson, E. B., Dementia in the elderly: The “silent epidemic” no more. Trans. Am. Clin. Climatol. Assoc. 112:136–148, 2001.PubMedPubMedCentral Larson, E. B., Dementia in the elderly: The “silent epidemic” no more. Trans. Am. Clin. Climatol. Assoc. 112:136–148, 2001.PubMedPubMedCentral
22.
go back to reference Durazzo, T. C., et al., Smoking and increased Alzheimer’s disease risk: A review of potential mechanisms. Alzheimers Dement. 10(3):S122–S145, 2014.PubMedPubMedCentralCrossRef Durazzo, T. C., et al., Smoking and increased Alzheimer’s disease risk: A review of potential mechanisms. Alzheimers Dement. 10(3):S122–S145, 2014.PubMedPubMedCentralCrossRef
23.
go back to reference Chen, R., Association of environmental tobacco smoke with dementia and Alzheimer’s disease among never smokers. Alzheimers Dement. 8(6):590–595, 2012.PubMedCrossRef Chen, R., Association of environmental tobacco smoke with dementia and Alzheimer’s disease among never smokers. Alzheimers Dement. 8(6):590–595, 2012.PubMedCrossRef
24.
go back to reference Brust, J. C., Ethanol and cognition: Indirect effects, neurotoxicity and neuroprotection: A review. Int. J. Environ. Res. Public Health 7(4):1540–1557, 2010.PubMedPubMedCentralCrossRef Brust, J. C., Ethanol and cognition: Indirect effects, neurotoxicity and neuroprotection: A review. Int. J. Environ. Res. Public Health 7(4):1540–1557, 2010.PubMedPubMedCentralCrossRef
25.
26.
go back to reference Xu, W., Tan, L., Wang, H. F., Jiang, T., Tan, M. S., Tan, L., Zhao, Q. F., Li, J. Q., Wang, J., and Yu, J. T., Meta-analysis of modifiable risk factors for Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry, 2015. doi:10.1136/jnnp-2015-310548. Xu, W., Tan, L., Wang, H. F., Jiang, T., Tan, M. S., Tan, L., Zhao, Q. F., Li, J. Q., Wang, J., and Yu, J. T., Meta-analysis of modifiable risk factors for Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry, 2015. doi:10.​1136/​jnnp-2015-310548.
27.
go back to reference Lu, F. P., Lin, K. P., and Kuo, H. K., Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 4(1):e4144, 2009.PubMedPubMedCentralCrossRef Lu, F. P., Lin, K. P., and Kuo, H. K., Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 4(1):e4144, 2009.PubMedPubMedCentralCrossRef
28.
go back to reference Rönnemaa, E., Zethelius, B., et al., Glucose metabolism and the risk of Alzheimer’s disease and dementia: A population-based 12 year follow-up study in 71-year-old men. Diabetologia 52(8):1504–1510, 2009.PubMedCrossRef Rönnemaa, E., Zethelius, B., et al., Glucose metabolism and the risk of Alzheimer’s disease and dementia: A population-based 12 year follow-up study in 71-year-old men. Diabetologia 52(8):1504–1510, 2009.PubMedCrossRef
Metadata
Title
What is Your Risk of Contracting Alzheimer’s Disease? A Telematics Tool Helps you to Predict it
Authors
Rodrigo Méndez-Sanz
Isabel de la Torre-Díez
Miguel López-Coronado
Publication date
01-01-2016
Publisher
Springer US
Published in
Journal of Medical Systems / Issue 1/2016
Print ISSN: 0148-5598
Electronic ISSN: 1573-689X
DOI
https://doi.org/10.1007/s10916-015-0369-1

Other articles of this Issue 1/2016

Journal of Medical Systems 1/2016 Go to the issue